![John A. Hey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John A. Hey
Directeur Technique/Scientifique/R&D chez
ALZHEON, INC.
Profil
John A. Hey is currently the Chief Scientific Officer at Alzheon, Inc. Prior to this, he was the Senior Director-Neurobiology at Schering-Plough Research Institute from 1988 to 2006.
He then served as the SVP-Discovery & Preclinical Drug Development at CoMentis, Inc. from 2006 to 2010, and as the Senior VP-Preclinical & Early Development at NormOxys, Inc. from 2010 to 2012.
Dr. Hey received his undergraduate degree from the University of Oklahoma.
Postes actifs de John A. Hey
| Sociétés | Poste | Début |
|---|---|---|
| ALZHEON, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de John A. Hey
| Sociétés | Poste | Fin |
|---|---|---|
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Corporate Officer/Principal | 01/01/2012 |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Corporate Officer/Principal | 01/01/2010 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Corporate Officer/Principal | 01/01/2006 |
Formation de John A. Hey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Oklahoma
 University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
